DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20221080

Spinal motor atrophy in a floppy infant: a case report

Kapil S. Bainade, Veeranna Kotrashetti, Vijay B. Sonawane, Rajdeep Agarwal

Abstract


Spinal muscular atrophy (SMA) is a progressive neuromuscular condition typically due to homozygous absence of the survival motor neuron gene (SMN1). It is characterized by progressive muscle weakness that limits motor development. Muscle weakness is associated with muscle atrophy and hypotonia, absence or marked decrease of deep tendon reflexes. Proximal muscles are more affected than distal muscles. Contractures and spinal deformity are a common impairment. Child with SMA gradually lose function over time. Electromyelography (EMG) and nerve conduction velocity shows anterior horn cells abnormality. No specific medical management is available for children with SMA. Interventions are usually supportive and may include physical therapy, occupational therapy, speech therapy, nutrition, orthotic management and possible surgery. This case report was of a 4 and half month-old female child with paucity of movement of lower limb since birth along with developmental delay.


Keywords


SMN, SMA, Nusinersen

Full Text:

PDF

References


Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012;20(1):27-32.

Munsat TL, Davies KE. International SMA consortium meeting. (26–28 June 1992, Bonn, Germany). Neuromuscul Disord. 1992;2(5-6):423-8.

Kolb SJ, Kissel JT. Spinal muscular atrophy: a timely review. Arch Neurol. 2011;68(8):979-84.

Arnold WD, Burghes AH. Spinal muscular atrophy: development and implementation of potential treatments. Ann Neurol. 2013;74(3):348-62.

Lorson CL, Rindt H, Shababi M. Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet. 2010;19(R1):111-8.

Wang CH, Finkel RS, Bertini ES, Scroth M, Simonds A, Wong B, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22(8):1027-49.

D'Amico A, Mercuri E, Tiziano FD, Bertini E. Spinal muscular atrophy. Orphanet J Rare Dis. 2011;6:71.

Finkel RS, McDermott MP, Kaufmann P, Darras BT, Chung WK, Sproule DM, et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology. 2014;83(9):810-7.

Finkel RS, Weiner DJ, Mayer OH, McDonough JM, Panitch HB. Respiratory muscle function in infants with spinal muscular atrophy type I. Pediatr Pulmonol. 2014;49(12):1234-42.

Oskoui M, Levy G, Garland CJ, Gray JM, O'Hagen J, De Vivo DC, et al. The changing natural history of spinal muscular atrophy type 1. Neurology. 2007;69(20):1931-6.

Boitano LJ. Equipment options for cough augmentation, ventilation, and noninvasive interfaces in neuromuscular respiratory management. Pediatrics. 2009;123(4):226-30.